Patents by Inventor Exelixis, Inc.

Exelixis, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of P13K-Alpha for the treament of cancer
    Publication number: 20130343988
    Abstract: The invention is directed to Compounds of Formula (I). The invention provides compounds that inhibit, regulate, and/or modulate P13K that are useful in the treatment of hyperproliferative diseases, such as cancer.
    Type: Application
    Filed: January 3, 2013
    Publication date: December 26, 2013
    Applicant: Exelixis, Inc.
    Inventor: Exelixis, Inc.
  • PFKs as Modifiers of the IGFR Pathway and Methods of Use
    Publication number: 20130212716
    Abstract: Human PFK genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of PFK are provided.
    Type: Application
    Filed: April 12, 2013
    Publication date: August 15, 2013
    Applicant: EXELIXIS, INC.
    Inventor: Exelixis, Inc.